Skip to content

A study to explore Digestive Strength and Inflammation Markers in Uncontrolled Diabetes Patients

An observational study of status of agni and level of high sensitivity c reactive protein(hs crp) in uncontrolled type 2 diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098132
Enrollment
60
Registered
2025-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil

Sponsors

Dr Romanharsh Mulchand Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of Type 2 DM with HbA1c more than 7 percentage 2.Cases of uncontrolled type 2 DM with diagnosed specific complications such as Diabetic Ketoacidosis, Diabetic nephropathy, Diabetic retinopathy, myopathy, osteoporosis et cetera 3.Age more than 18 yrs

Exclusion criteria

Exclusion criteria: 1.Type 1 DM 2.Autoimmune diseases 3.Patients with other Severe Infections, disease conditions other than complications of uncontrolled type 2 DM 4.Patients on Immunosuppressants Corticosteroids and Nonsteroidal anti inflammatory drugs 5.Pregnancy and lactating mother 6.Patients undergone surgery more than 3 months

Design outcomes

Primary

MeasureTime frame
High Sensitivity C-Reactive Protein as a marker for severity of AgnimandyaTimepoint: At baseline

Secondary

MeasureTime frame
Mandagni as a status of Agni in Uncontrolled Diabetes Mellitus PatientsTimepoint: At baseline

Countries

India

Contacts

Public ContactDr Lata Dhananjay Patil

Bharati Vidyapeeth (Deemed To Be University) Pune

lata.patil1@bharatividyapeeth.edu9403782465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026